Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
32 studies found for:    " September 25, 2013":" October 25, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed The Safety and Immunogenicity of a Potential HIV Vaccine
Condition: HIV Infections
Intervention: Biological: CN54gp140 mixed with GLA-AF
2 Completed
Has Results
PENTA15: Pharmacokinetic Study of Once Versus Twice Daily Abacavir in HIV-1 Infected Children Aged 3 to <36 Months
Condition: HIV Infection
Interventions: Other: Intervention 1: PK assessment while on Twice Daily Abacavir;   Other: Intervention 2: PK assessment while on Once Daily Abacavir
3 Withdrawn Evaluating the Safety and Immune Response to Three Different Prime-Boost HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA Nat-B env vaccine;   Biological: NYVAC Nat-B env vaccine;   Biological: DNA CON-S env vaccine;   Biological: NYVAC CON-S env vaccine;   Biological: DNA Mosaic env vaccine;   Biological: NYVAC Mosaic env vaccine;   Biological: Placebo;   Device: Biojector 2000® Needle-Free Injection Management System™ (Biojector 2000®)
4 Withdrawn Evaluating the Safety and Immune Response to Five Different Combinations of HIV Vaccines in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123;   Biological: NYVAC-HIV-PT1;   Biological: NYVAC-HIV-PT4;   Biological: AIDSVAX B/E®;   Biological: Placebo vaccine
5 Completed Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children
Condition: HIV Infection
Interventions: Drug: ABC Twice Daily;   Drug: ABC Once Daily;   Drug: 3TC Once Daily;   Drug: 3TC Twice Daily
6 Active, not recruiting Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults
Conditions: HIV;   HIV Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: TAF;   Drug: Placebo to match TAF;   Drug: E/C/F/TAF;   Drug: Pre-existing ARV regimen;   Drug: ATV
7 Completed
Has Results
Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults
Conditions: HIV-1;   HIV Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: E/C/F/TAF;   Drug: DRV;   Drug: Pre-existing ARV regimen
8 Completed Comparing Food and Cash Assistance for HIV-Positive Men and Women on Antiretroviral Therapy in Tanzania
Condition: HIV
Interventions: Other: NAC (Nutritional Assessment and Counseling);   Other: Cash Transfer;   Other: Food Assistance
9 Completed Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 Patients
Condition: HIV-1 Infection
Interventions: Drug: Raltegravir;   Drug: Efavirenz
10 Recruiting Bone Antiresorptive Therapy With Antiretroviral Initiation (BATARI) Pilot Trial
Condition: HIV
Intervention: Drug: alendronate/vitamin D
11 Completed Feasibility of an Exercise Intervention
Condition: HIV
Intervention: Other: HOME-EX
12 Not yet recruiting Comparing the Effectiveness of Two Alcohol+Adherence Interventions for HIV+ Youth
Condition: HIV
Intervention: Behavioral: Motivational Enhancement Therapy (MET)
13 Completed Mother Infant Retention for Health: MIR4Health
Condition: HIV/AIDS
Intervention: Behavioral: Study Intervention for Retention (APFU)
14 Unknown  Modified Directly Observed Antiretroviral Therapy
Condition: HIV
Intervention: Other: Home visits
15 Enrolling by invitation Botswana Combination Prevention Project
Condition: HIV
Interventions: Other: Combination Prevention;   Other: Enhanced Care
16 Active, not recruiting Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy Switch to an Raltegravir-based Regimen
Conditions: HIV;   HIV-associated Neurocognitive Disorder;   Neurotoxicity
Intervention: Drug: switch efavirenz (EFV) to raltegravir (RAL)
17 Completed Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal Women
Condition: Human Immunodeficiency Virus
Intervention: Drug: Dapivirine Vaginal Ring
18 Completed Effect of Carbamazepine on Dolutegravir Pharmacokinetics in Healthy Adult Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: DTG;   Drug: CBZ
19 Completed
Has Results
Real-Time Antiretroviral Therapy Adherence Intervention in Uganda
Conditions: HIV/AIDS;   Adherence
Interventions: Device: Fixed SMS, real-time monitoring;   Device: Triggered SMS, real-time monitoring
20 Completed Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Protease Inhibitors To Dolutegravir In HIV-1-Infected Subjects With Low Bone Mineral Density
Condition: HIV-1 Infection
Interventions: Drug: Dolutegravir, 50mg every 24 hours;   Drug: Protease Inhibitor/ritonavir

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.